KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 128 filers reported holding KYMERA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,434,327 | -42.6% | 103,189 | -5.1% | 0.02% | -43.3% |
Q2 2023 | $2,500,875 | -15.6% | 108,781 | +8.8% | 0.03% | -25.0% |
Q1 2023 | $2,963,296 | +18.7% | 100,010 | +0.0% | 0.04% | +21.2% |
Q4 2022 | $2,496,000 | +14.7% | 100,000 | 0.0% | 0.03% | +10.0% |
Q3 2022 | $2,177,000 | +10.6% | 100,000 | 0.0% | 0.03% | 0.0% |
Q2 2022 | $1,969,000 | -74.1% | 100,000 | -22.7% | 0.03% | -75.8% |
Q3 2021 | $7,597,000 | +314.9% | 129,331 | +242.5% | 0.12% | +264.7% |
Q2 2021 | $1,831,000 | -82.6% | 37,759 | -77.7% | 0.03% | -87.8% |
Q4 2020 | $10,521,000 | +95.9% | 169,687 | +2.1% | 0.28% | +58.5% |
Q3 2020 | $5,370,000 | – | 166,217 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
AtonRa Partners | 34,462 | $750,000 | 0.74% |
Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |